Advaxis names VP, clinical ops
This article was originally published in Scrip
Advaxis, a clinical-stage biotechnology company developing cancer immunotherapies, has appointed Thomas W Hare vice-president of clinical operations. Mr Hare brings to Advaxis more than 28 years of experience in the biopharmaceutical and contract research organization industries overseeing the management of global commercial and clinical operations, data management, outsourcing and medical writing groups. Most recently, he was vice-president of drug development operations at Incyte. In his new role he will report to Advaxis' executive vice-president, chief medical officer, Dr David J Mauro, and will oversee clinical operations for the company's multiple Lm-LLO cancer immunotherapy clinical programs.